Manufacturers Life Insurance Company, The Atreca, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$7.82 - $13.8 $140,204 - $247,420	-17,929 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$13.0 - $19.34 $1,742 - $2,591	-134 Reduced 0.74%	17,929 $275,000
Q4 2020 Feb 12, 2021	BUY	$13.03 - $17.09 $26,138 - $34,282	2,006 Added 12.49%	18,063 $292,000
Q3 2020 Nov 09, 2020	BUY	$12.67 - $23.19 $37,477 - $68,596	2,958 Added 22.58%	16,057 $224,000
Q2 2020 Aug 10, 2020	BUY	$12.52 - $23.45 $30,849 - $57,780	2,464 Added 23.17%	13,099 $270,000
Q1 2020 May 15, 2020	BUY	$11.4 - $27.28 $121,239 - $290,122	10,635 New	10,635 $176,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.